BCR and myeloproliferative neoplasm: Altogether, the clinicopathologic and molecular findings supported the diagnosis of PMF (with CALR mutation) and subsequent occurrence of the BCR::ABL1 rearrangement, therefore, interpretable as the coexistence of a Ph-negative MPN with CML.